LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
  • Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

    Number three written on white chat bubble on blue background
    Investing Articles

    The UK stock market is brimming with hidden value. Here are some top picks to consider in July

    I'm looking for the most promising shares on the UK stock market this month. Here are three that I think…

    Read more »

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April

    I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to…

    Read more »

    Investing Articles

    2 FTSE 100 shares investors should consider buying for a winning portfolio

    Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost…

    Read more »

    Investing Articles

    £9,000 in excess savings? I’d buy 457 shares of this dividend stock to target a £1,100 extra income

    Dividend stocks that consistently boost payouts can offer investors massive yields long term. Here’s a share that may be on…

    Read more »

    British flag, Big Ben, Houses of Parliament and British flag composition
    Investing Articles

    These were the best performers on the FTSE 100 in January

    The FTSE 100 might have got off to a slow start this year, but these top-performing stocks certainly didn't. Why…

    Read more »

    Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
    Investing Articles

    I reckon this FTSE 100 stock, around 35% below its high, is cheap and growing fast!

    Our writer has found a FTSE 100 company that he thinks has top-class margins and revenue growth rates at an…

    Read more »

    Young Asian man drinking coffee at home and looking at his phone
    Investing Articles

    Can this FTSE 100 stock grow 2x in 2 years?

    The FTSE-listed generic manufacturer has been overlooked by many since joining the blue-chip index. Dr James Fox takes a closer…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Is the Hikma Pharmaceuticals share price becoming cheap?

    The Hikma Pharmaceuticals share price dipped after a trading update on Thursday 2 November. Dr James Fox explores whether this…

    Read more »

    artificial intelligence investing algorithms
    Investing Articles

    Is this FTSE pharma stock a no-brainer buy?

    Our writer takes a closer look at this FTSE pharmaceutical business and decides whether or not it could be a…

    Read more »

    Black woman using loudspeaker to be heard
    Investing Articles

    I’d buy 2,430 shares of this stock for £100 in monthly passive income

    Zaven Boyrazian explores one recovering healthcare company with a small yield and the potential to propel dividends to new heights…

    Read more »

    Happy young female stock-picker in a cafe
    Investing Articles

    2 UK dividend stocks I’d buy today

    I think the growing stream of income from these two UK dividend stocks would sit well in my diversified portfolio…

    Read more »

    Young female analyst working at her desk in the office
    Investing Articles

    2 stocks ready to bounce back

    The stock market is full of recovering stocks and I think these two look set to move higher driven by…

    Read more »